David H. Watson - 16 Apr 2026 Form 4 Insider Report for ARGAN INC (AGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Apr 2026, 17:00:11 UTC
Prior SEC filing
10 Apr 2026
Next SEC filing
16 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David H. Watson

Key filing fact

David H. Watson filed Form 4 for ARGAN INC (AGX) on 20 Apr 2026.

Key facts

  • This page summarizes David H. Watson's Form 4 filing for ARGAN INC (AGX).
  • 11 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 20 Apr 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 10 Apr 2026.
  • Current net transaction value: -$11,626,744.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001482442 Primary reporting owner

Watson David Hibbert

Relationship
PRESIDENT AND CEO, Director
Address
4075 WILSON BOULEVARD, SUITE 440, ARLINGTON
Signature
/s/ David H. Watson
Signature date
20 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,869
Change %
+4%
Price
$0.000000*
Shares after
49,001
Date
16 Apr 2026
Ownership
Direct
Footnotes
F1
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+736
Change %
+1.5%
Price
$0.000000*
Shares after
49,737
Date
16 Apr 2026
Ownership
Direct
Footnotes
F2
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,302
Change %
+4.6%
Price
$0.000000*
Shares after
52,039
Date
17 Apr 2026
Ownership
Direct
Footnotes
F3
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+11,513
Change %
+22%
Price
$0.000000*
Shares after
63,552
Date
17 Apr 2026
Ownership
Direct
Footnotes
F4
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,756
Change %
+9.1%
Price
$0.000000*
Shares after
69,308
Date
17 Apr 2026
Ownership
Direct
Footnotes
F5
AGX transaction

Common Stock

Sale

Transaction value
$11,626,744
Shares
-19,310
Change %
-28%
Price
$602.11
Shares after
49,998
Date
17 Apr 2026
Ownership
Direct
Footnotes
F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGX transaction Derivative

Time-Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-3,333
Change %
-22%
Price
$0.000000*
Shares after
11,585
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,333
Exercise price
$0.000000
Footnotes
F1
AGX transaction Derivative

Time-Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,333
Change %
-12%
Price
$0.000000*
Shares after
10,252
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,333
Exercise price
$0.000000
Footnotes
F2
AGX transaction Derivative

Time-Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-4,000
Change %
-39%
Price
$0.000000*
Shares after
6,252
Date
17 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,000
Exercise price
$0.000000
Footnotes
F3
AGX transaction Derivative

Earnings Per Share Performance-Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-10,000
Change %
-35%
Price
$0.000000*
Shares after
18,839
Date
17 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$0.000000
Footnotes
F4
AGX transaction Derivative

Performance-Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-5,000
Change %
-41%
Price
$0.000000*
Shares after
7,284
Date
17 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$0.000000
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Footnote F2

Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Footnote F3

Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends.

Footnote F4

Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000.

Footnote F5

Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000.

Footnote F6

On April 17, 2026, the Reporting Person sold 19,310 shares of the Issuer's common stock on the open market at an average price of $602.11 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .